Press release - 14/10/2009 mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million) mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, announced on 14th October the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company’s last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/mtm-laboratories-extends-series-c-financing-round-by-eur-7-million-bringing-total-to-eur-39-million
Press release - 30/09/2009 New managing director for BioRegion Rhein-Neckar-Dreieck e.V. Biotech expert Dr. Julia Schüler is leaving Ernst Young to join BioRegion Rhein-Neckar-Dreieck e.V. Rhine-Neckar BioRegion. The biologist is to succeed Ernst-Dieter Jarasch the associations managing director since its establishment in 1996.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-managing-director-for-bioregion-rhein-neckar-dreieck-e-v
Press release - 24/09/2009 CeGAT: Tracking genes using cutting-edge technologies To adequately meet the growing demand for genetic diagnostics doctor scientist and bioinformatician Dr. Saskia Biskup and her husband business graduate Dr. Dirk Biskup founded the Center for Genomics and Transcriptomics or CeGAT for short in July 2009. As a supplier of DNA and RNA sequencing in the STERN BioRegion CeGAT which is based in the Technology park Tübingen Reutlingen TTR uses state-of-the-art high-throughput technologies to examine…https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-tracking-genes-using-cutting-edge-technologies
Press release - 18/09/2009 Why don’t brain tumours respond to drugs? Malignant brain tumours do not often respond to promising new drugs. Researchers from Heidelberg have now uncovered a mechanism and a tumour marker that are linked to the development of this resistance. A “death receptor” might possibly indicate the chances of success of chemotherapy at the same time as providing new approaches for developing a new therapy for the successful treatment of brain tumours.https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-don-t-brain-tumours-respond-to-drugs
Press release - 14/09/2009 Launch of SAFE-T Consortium: Translational Safety Biomarkers "Faster Development of Safer Medicines through Translational Safety Biomarkers": On September 14, 2009, the Safer And Faster Evidence-based Translation (SAFE-T) consortium project under the EU Innovative Medicines Initiative - Joint Undertaking (IMI-JU) was presented at the EUROTOX 2009 conference in Dresden. The consortium announces the start of work to qualify biomarkers for drug-induced kidney, liver and vascular injury in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/launch-of-safe-t-consortium-translational-safety-biomarkers
Article - 14/09/2009 SensScreen Technologies: Magnetic separation to conquer biotechnological areas of application In terms of protein purification, the biopharmaceutical industry is increasingly reaching its technical and economic limits. The currently used chromatography procedures are expensive, time-consuming and associated with high product losses due to the large number of individual processing steps involved. Special magnetic microparticles, such as those developed by the chemist Dr. Jochen F. Peter with his recently established company SensScreen…https://www.gesundheitsindustrie-bw.de/en/article/news/sensscreen-technologies-magnetic-separation-to-conquer-biotechnological-areas-of-application
Article - 03/09/2009 Company establishment with combined forces The company DSL a specialist in molecular diagnostics is currently being established in the city of Eriskirch close to Friedrichshafen Germany. The future managing directors Dr. Sabine Lautenschläger and Dr. Daniel Schaarschmidt are being supported by the BioLAGO network and the pharmaceutical company Nycomed.https://www.gesundheitsindustrie-bw.de/en/article/news/company-establishment-with-combined-forces
Article - 12/08/2009 More effective extraction of small RNAs Small RNAs are gaining in importance in research as well as in the biotechnology and pharmaceutical industries. However the potential of these molecules can only be exploited fully if very pure RNAs can be extracted from the cells in sufficiently high quantities. Currently used methods are expensive and only designed for large cell quantities. In addition the operation of the extraction systems is very complicated. A new biochip developed by Dr.…https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-extraction-of-small-rnas
Press release - 10/08/2009 Biomarkers help predict the risk of Alzheimer’s in patients with mild cognitive impairment A large multicentre study has shown that CSF (cerebrospinal fluid) biomarkers can be used to predict, with good accuracy, as to which patients with mild cognitive impairments will develop Alzheimer’s disease. The biomarkers used are microtubule-associated proteins that are abundant in CNS neurons as well as beta amyloid, which is a peptide that forms brain plaques in people with Alzheimer’s disease. Changes in the concentrations of these proteins…https://www.gesundheitsindustrie-bw.de/en/article/press-release/biomarkers-help-predict-the-risk-of-alzheimer-s-in-patients-with-mild-cognitive-impairment
Article - 06/08/2009 PEPperPRINT wins award for its peptide chips PEPperPRINT GmbH, a spin-off of the German Cancer Research Centre, has won the Science4Life Venture Cup, a German start-up contest that comes with the most prize money. The Heidelberg-based start-up company was previously awarded the renowned research prize by the German Stifterverband and was chosen as a “Landmark in the Land of Ideas” competition run by the German government in 2009.https://www.gesundheitsindustrie-bw.de/en/article/news/pepperprint-wins-award-for-its-peptide-chips
Article - 30/07/2009 Dragnet investigation for substance killers The Ulm-based company Labor Dr. Merk Kollegen with over 40 employees is a specialist company identifying foreign bodies such as viruses bacteria and toxins in biopharmaceuticals and medical products. In addition the medium-sized company has been developing producing and marketing diagnostics for medical use for almost 40 years.https://www.gesundheitsindustrie-bw.de/en/article/news/dragnet-investigation-for-substance-killers
Press release - 28/07/2009 Fostering enthusiasm for successful entrepreneurship BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH!…https://www.gesundheitsindustrie-bw.de/en/article/press-release/fostering-enthusiasm-for-successful-entrepreneurship
Dossier - 16/07/2009 Patents – the exploitations of inventions in the life sciences According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…https://www.gesundheitsindustrie-bw.de/en/article/dossier/patents-the-exploitations-of-inventions-in-the-life-sciences
Press release - 07/07/2009 Investment in the future: ILM receives funds for the purchase of equipment The Ulm-based Institute for Laser Technologies in Medicine and Metrology (ILM) has received a 335,000 euro injection in 2009 through the German government’s Future Investment Programme (Economic Stimulus Packet II), according to the Baden-Württemberg Minister of Economic Affairs Ernst Pfister. The funds, 75 per cent of which are provided by the German government and 25 per cent by the state of Baden-Württemberg, will be used for the modernisation…https://www.gesundheitsindustrie-bw.de/en/article/press-release/investment-in-the-future-ilm-receives-funds-for-the-purchase-of-equipment
Article - 02/07/2009 A virus that hides while it waits for an opportunity to replicate Thomas Mertens, Medical Director of the Institute of Virology in Ulm, has a strong scientific and clinical interest in the human cytomegalovirus (HCMV), a big virus with a big impact which, despite its size, is overshadowed by known viruses such as the HI virus that is the object of research for Mertens’ colleagues. HCMV research is a challenging area where quick successes are rare.https://www.gesundheitsindustrie-bw.de/en/article/news/a-virus-that-hides-while-it-waits-for-an-opportunity-to-replicate
Press release - 30/06/2009 febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment In the near future, Next-Generation Sequencing technologies will lead to a rising number of completed genomes of model organisms and other species of interest, as demonstrated by the updated mouse genome. This accelerated development will generate a variety of tools available in the short term for the application of the new data into experiments. febit’s technology enables the conversion of new sequence data into biochips for gene expression…https://www.gesundheitsindustrie-bw.de/en/article/press-release/febit-first-to-offer-newly-published-mouse-genome-on-a-chip-for-dna-rna-detection-and-enrichment
Press release - 29/06/2009 Can loss of sense of smell predict Alzheimer’s The first lapses of memory go hand in hand with a loss of the sense of smell: The olfactory centre in the brain of Alzheimer’s patients is wasting away. The olfactory bulb starts to shrink at a very early stage of the disease, at a time when retentiveness is only slightly affected. It is possible to detect the shrinkage of the olfactory bulb with magnetic resonance imaging, as the latest findings by scientists of the Department of Psychiatry at…https://www.gesundheitsindustrie-bw.de/en/article/press-release/can-loss-of-sense-of-smell-predict-alzheimer-s
Article - 29/06/2009 Alternative protein structures and breast cancer A single protein can have many variants. This variability is achieved by a process known as splicing which can introduce small modifications into the mRNA transcript of a gene. Prof. Dr. Elmar Stickeler from the University Womens Hospital in Freiburg found that some of these splice variants can also induce cancer. Stickeler and his team are investigating how splicing factors change their target molecules and how this leads to breast cancer. This…https://www.gesundheitsindustrie-bw.de/en/article/news/alternative-protein-structures-and-breast-cancer
Press release - 22/06/2009 Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN) The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-start-cooperative-projects-of-the-rhine-neckar-biotechnology-cluster-biorn
Press release - 22/06/2009 MRI for tracing living cells Researchers from the Mannheim Medical Faculty which is part of Heidelberg University and the Max Planck Institute MPI for Biological Cybernetics in Tübingen have achieved a world first in the use of magnetic resonance imaging MRI for the simultaneous visualisation of sodium and potassium ions which are important for proper cell function in the living cell. The scientists from the Mannheim Medical Faculty have thus achieved an important milestone…https://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-for-tracing-living-cells
Article - 10/06/2009 Colleagues who became customers Should they work with a long-standing cooperation partner or should they set up another company that was the decision faced by the staff of the Discovery-IT department of Nycomed formerly ALTANA Pharma in the spring of 2007.https://www.gesundheitsindustrie-bw.de/en/article/news/colleagues-who-became-customers
Press release - 10/06/2009 6.56 million euros for first full-body PET-MRI prototype The Joint Science Conference in Bonn has announced that the University of Tübingen will receive 6.56 million euros for the purchase of an entirely new multimodal full-body tomography system for the diagnosis of cancer. The new full-body PET-MRI combines positron emission tomography PET with magnetic resonance imaging MRI in one device.https://www.gesundheitsindustrie-bw.de/en/article/press-release/6-56-million-euros-for-first-full-body-pet-mri-prototype
Article - 09/06/2009 We would gladly finance more biotechs For four years, the High-Tech Gründerfonds (high-tech company establishment fund) has been supporting technology-oriented company founders. The project, which is backed by the Federal German government and major businesses, has 272 million euros of largely federal funds at its disposal, and its objective is the accelerated marketability of ideas. We spoke with Marco Winzer, representative and Investment Director at High-Tech Gründerfonds,…https://www.gesundheitsindustrie-bw.de/en/article/news/we-would-gladly-finance-more-biotechs
Press release - 28/05/2009 CONCERT Medical Optics wins special CyberOne prize The company CONCERT Medical Optics was selected from more than 70 participants from all over Germany to receive a special CyberOne prize for the most innovative start-up concept namely a medical instrument called EndoTherapeuthoSkop. This instrument combines different technologies enabling the simultaneous detection and treatment of tumours meaning that patients only have to undergo one rather than several interventions.https://www.gesundheitsindustrie-bw.de/en/article/press-release/concert-medical-optics-wins-special-cyberone-prize
Article - 27/05/2009 Raimund Hibst brings laser into dental practices Nowadays, in many dental practices drills are no longer used to remove caries – much to the patients’ delight. Such practices have replaced drills with lasers, a virtually painless method, with low noise levels and which does not require a local anaesthetic. This is all thanks to the work of Raimund Hibst, a physicist from the ILM in Ulm who has spent many years turning research findings into health market applications, in cooperation with…https://www.gesundheitsindustrie-bw.de/en/article/news/raimund-hibst-brings-laser-into-dental-practices